title: Editorial: safety and tolerability of rifaximin for IBS - more information is required.
authors.affiliation: Institute of Digestive Diseases, the Chinese PLA General Hospital, the Chinese PLA Medical Academy, Beijing, China. sunny301ddc@126.com.
authors.forename: S-T
authors.initials: ST
authors.lastname: Cai
authors.forename: Y-S
authors.initials: YS
authors.lastname: Yang
mesh_terms: D005260:Female; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000188:drug therapy*; D008297:Male; D012294:Rifamycins / Q000009:adverse effects*
chemical_list: D005765:Gastrointestinal Agents; D012294:Rifamycins